Document Detail


The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
MedLine Citation:
PMID:  16982234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: This retrospective study reports of 85 women in the second trimester with one prior cesarean section undergoing medical abortion of a viable unwanted pregnancy using vaginal misoprostol. Two regimens that were selected in a nonrandomized manner were used. MATERIALS AND METHODS: Eighty-five women treated with vaginal misoprostol in a 3-year period were retrospectively analyzed. All received 400 mug of misoprostol initially and 22 (25.8%) aborted. Then Group A (n=43) received subsequent administration of 200 microg every 6 h, whereas Group B (n=20) received 400 microg/6 h. RESULTS: All patients aborted. The groups had no statistical difference in mean age, gravidity, parity, gestational age, and time from previous cesarean section, and there was no difference in occurrence of side effects and mean induction to abortion time interval. The lower dosage group received a median of 600 microg of vaginal misoprostol (min 600 microg to max 1000 microg). There were no uterine ruptures, need for hysterotomy, or excess bleeding in any patient. CONCLUSIONS: This is the largest series reported to date of second-trimester pregnancy termination in cases with one previous cesarean section using only vaginal misoprostol. The study shows that both used regimens are safe and equally effective. All 85 women aborted.
Authors:
Alexandros Daponte; Guy Nzewenga; Konstantinos D Dimopoulos; Franco Guidozzi
Related Documents :
4033154 - Speculations on the origin of the ill-effects associated with the use of visual display...
8513674 - Midtrimester induction of abortion: comparison of extraovular prostaglandin e2 and intr...
11574654 - Screening for disability: a eugenic pursuit?
7199914 - Pregnancy termination in dogs with novel non-hormonal compounds. studies of 2-(3-ethoxy...
17094044 - Relationship between intertwin delivery interval and metabolic acidosis in the second t...
6698214 - Culture factors in relation to the success of human in vitro fertilization and embryo t...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article     Date:  2006-05-12
Journal Detail:
Title:  Contraception     Volume:  74     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-19     Completed Date:  2007-02-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  United States    
Other Details:
Languages:  eng     Pagination:  324-7     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, University Hospital of Larissa, University of Thessalia, Larissa 41110, Greece. dapontea@otenet.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage
Abortion, Induced / methods*
Administration, Intravaginal
Adolescent
Adult
Cesarean Section*
Dose-Response Relationship, Drug
Female
Gestational Age
Gravidity
Humans
Misoprostol / administration & dosage*
Parity
Pregnancy
Pregnancy Trimester, Second / drug effects*
Retrospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Utilization of contraception and abortion and its relationship to HIV infection among female sex wor...
Next Document:  Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion:...